

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Pentamethylethane
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : GSK | Currax
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Triptan is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Migraine Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 15, 2010
Lead Product(s) : Pentamethylethane
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : GSK | Currax
Deal Size : Inapplicable
Deal Type : Inapplicable
